Correlation Between IShares Healthcare and IShares Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Healthcare and IShares Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Healthcare and IShares Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Healthcare ETF and iShares Pharmaceuticals ETF, you can compare the effects of market volatilities on IShares Healthcare and IShares Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Healthcare with a short position of IShares Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Healthcare and IShares Pharmaceuticals.

Diversification Opportunities for IShares Healthcare and IShares Pharmaceuticals

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between IShares and IShares is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding iShares Healthcare ETF and iShares Pharmaceuticals ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Pharmaceuticals and IShares Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Healthcare ETF are associated (or correlated) with IShares Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Pharmaceuticals has no effect on the direction of IShares Healthcare i.e., IShares Healthcare and IShares Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares Healthcare and IShares Pharmaceuticals

Considering the 90-day investment horizon iShares Healthcare ETF is expected to under-perform the IShares Pharmaceuticals. But the etf apears to be less risky and, when comparing its historical volatility, iShares Healthcare ETF is 1.09 times less risky than IShares Pharmaceuticals. The etf trades about -0.03 of its potential returns per unit of risk. The iShares Pharmaceuticals ETF is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  6,920  in iShares Pharmaceuticals ETF on December 4, 2024 and sell it today you would earn a total of  285.00  from holding iShares Pharmaceuticals ETF or generate 4.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

iShares Healthcare ETF  vs.  iShares Pharmaceuticals ETF

 Performance 
       Timeline  
iShares Healthcare ETF 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days iShares Healthcare ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, IShares Healthcare is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
iShares Pharmaceuticals 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Pharmaceuticals ETF are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, IShares Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

IShares Healthcare and IShares Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Healthcare and IShares Pharmaceuticals

The main advantage of trading using opposite IShares Healthcare and IShares Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Healthcare position performs unexpectedly, IShares Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Pharmaceuticals will offset losses from the drop in IShares Pharmaceuticals' long position.
The idea behind iShares Healthcare ETF and iShares Pharmaceuticals ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk